Trials / Completed
CompletedNCT01107431
Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and Insulin
A Combination of L-Arabinose and Chromium Lowers Circulating Glucose and Insulin Levels After Acute Oral Sucrose Challenge
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Integrative Health Technologies, Inc. · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study was designed to examine changes in capillary blood glucose and venous insulin levels after a 70 gram oral sucrose challenge with and without simultaneous consumption of a dietary supplement containing L-Arabinose and a patented version of chromium (LA-Cr).
Detailed description
This study concluded that consumption of the LA-Cr supplement in conjunction with a 70-gram sucrose challenge led to a significant reduction of capillary blood glucose and venous insulin as compared to the sucrose challenge without the LA-Cr supplement. This finding may provide an important tool to reduce the adverse effects associated with elevated glucose and insulin levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | L-Arabinose and Chromium | Consumed 70 grams of sucrose simultaneously taking a dietary supplement |
| DIETARY_SUPPLEMENT | Sucrose without dietary Supplement | Repeated measures on subjects taking 70 grams of sucrose along with taking a dietary supplement containing L-Arabinose and Chromium |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2010-04-21
- Last updated
- 2011-05-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01107431. Inclusion in this directory is not an endorsement.